GUARDANT HEALTH, INC. Research and Development Expense
GUARDANT HEALTH, INC. (GH) reported Research and Development Expense of $96.53 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2026-07-30
- GUARDANT HEALTH, INC. research and development expense for the quarter ending 2026-06-30 was $96.53M, a 10.39% increase year-over-year.
- GUARDANT HEALTH, INC. research and development expense for the quarter ending 2026-03-31 was $91.04M, a 2.84% increase year-over-year.
- GUARDANT HEALTH, INC. research and development expense for the quarter ending 2025-12-31 was $98.26M, a 5.05% increase year-over-year.
- GUARDANT HEALTH, INC. research and development expense for the quarter ending 2025-09-30 was $89.96M, a 3.04% increase year-over-year.
- GUARDANT HEALTH, INC. research and development expense for fiscal 2025 was $364.19M, a 4.73% increase from fiscal 2024.
- GUARDANT HEALTH, INC. research and development expense for fiscal 2024 was $347.75M, a 5.29% decline from fiscal 2023.
- GUARDANT HEALTH, INC. research and development expense for fiscal 2023 was $367.19M, a 1.77% decline from fiscal 2022.
- GUARDANT HEALTH, INC. research and development expense for fiscal 2022 was $373.81M, a 42.01% increase from fiscal 2021.
| Period end | Research and Development Expense 3 month | Research and Development Expense 6 month | Research and Development Expense 9 month | Research and Development Expense 12 month |
|---|---|---|---|---|
| 2026-06-30 | $96.53M 10-Q · filed 2026-07-30 | $187.57M 10-Q · filed 2026-07-30 | $285.83M derived: sum of 3 quarters · filed 2026-07-30 | $375.79M derived: sum of 4 quarters · filed 2026-07-30 |
| 2026-03-31 | $91.04M 10-Q · filed 2026-05-07 | $189.30M derived: sum of 2 quarters · filed 2026-05-07 | $279.26M derived: sum of 3 quarters · filed 2026-05-07 | $366.71M derived: sum of 4 quarters · filed 2026-07-30 |
| 2025-12-31 | $98.26M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $188.22M derived: sum of 2 quarters · filed 2026-02-19 | $275.67M derived: sum of 3 quarters · filed 2026-07-30 | $364.19M 10-K · filed 2026-02-19 |
| 2025-09-30 | $89.96M 10-Q · filed 2025-10-29 | $177.41M derived: sum of 2 quarters · filed 2026-07-30 | $265.93M 10-Q · filed 2025-10-29 | $359.47M derived: sum of 4 quarters · filed 2026-07-30 |
| 2025-06-30 | $87.45M 10-Q · filed 2026-07-30 | $175.97M 10-Q · filed 2026-07-30 | $269.51M derived: sum of 3 quarters · filed 2026-07-30 | $356.82M derived: sum of 4 quarters · filed 2026-07-30 |
| 2025-03-31 | $88.52M 10-Q · filed 2026-05-07 | $182.06M derived: sum of 2 quarters · filed 2026-05-07 | $269.37M derived: sum of 3 quarters · filed 2026-05-07 | $352.47M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | $93.54M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $180.85M derived: sum of 2 quarters · filed 2026-02-19 | $263.95M derived: sum of 3 quarters · filed 2026-02-19 | $347.75M 10-K · filed 2026-02-19 |
| 2024-09-30 | $87.31M 10-Q · filed 2025-10-29 | $170.41M derived: sum of 2 quarters · filed 2025-10-29 | $254.21M 10-Q · filed 2025-10-29 | $344.07M derived: sum of 4 quarters · filed 2026-02-19 |
| 2024-06-30 | $83.10M 10-Q · filed 2025-07-30 | $166.90M 10-Q · filed 2025-07-30 | $256.76M derived: sum of 3 quarters · filed 2026-02-19 | $350.61M derived: sum of 4 quarters · filed 2026-02-19 |
| 2024-03-31 | $83.80M 10-Q · filed 2025-04-30 | $173.66M derived: sum of 2 quarters · filed 2026-02-19 | $267.51M derived: sum of 3 quarters · filed 2026-02-19 | $357.87M derived: sum of 4 quarters · filed 2026-02-19 |
| 2023-12-31 | $89.86M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $183.71M derived: sum of 2 quarters · filed 2026-02-19 | $274.07M derived: sum of 3 quarters · filed 2026-02-19 | $367.19M 10-K · filed 2026-02-19 |
| 2023-09-30 | $93.85M 10-Q · filed 2024-11-06 | $184.21M derived: sum of 2 quarters · filed 2024-11-06 | $277.34M 10-Q · filed 2024-11-06 | $383.92M derived: sum of 4 quarters · filed 2025-02-20 |
| 2023-06-30 | $90.36M 10-Q · filed 2024-08-07 | $183.49M 10-Q · filed 2024-08-07 | $290.06M derived: sum of 3 quarters · filed 2025-02-20 | $390.08M derived: sum of 4 quarters · filed 2025-02-20 |
| 2023-03-31 | $93.13M 10-Q · filed 2024-05-09 | $199.71M derived: sum of 2 quarters · filed 2025-02-20 | $299.72M derived: sum of 3 quarters · filed 2025-02-20 | $385.18M derived: sum of 4 quarters · filed 2025-02-20 |
| 2022-12-31 | $106.58M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-20 | $206.59M derived: sum of 2 quarters · filed 2025-02-20 | $292.05M derived: sum of 3 quarters · filed 2025-02-20 | $373.81M 10-K · filed 2025-02-20 |
| 2022-09-30 | $100.02M 10-Q · filed 2023-11-06 | $185.47M derived: sum of 2 quarters · filed 2023-11-06 | $267.23M 10-Q · filed 2023-11-06 | $340.25M derived: sum of 4 quarters · filed 2024-02-22 |
| 2022-06-30 | $85.45M 10-Q · filed 2023-08-03 | $167.21M 10-Q · filed 2023-08-03 | $240.23M derived: sum of 3 quarters · filed 2024-02-22 | $311.20M derived: sum of 4 quarters · filed 2024-02-22 |
| 2022-03-31 | $81.76M 10-Q · filed 2023-05-09 | $154.78M derived: sum of 2 quarters · filed 2024-02-22 | $225.75M derived: sum of 3 quarters · filed 2024-02-22 | $289.47M derived: sum of 4 quarters · filed 2024-02-22 |
| 2021-12-31 | $73.02M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-22 | $143.99M derived: sum of 2 quarters · filed 2024-02-22 | $207.71M derived: sum of 3 quarters · filed 2024-02-22 | $263.22M 10-K · filed 2024-02-22 |
| 2021-09-30 | $70.97M 10-Q · filed 2022-11-03 | $134.69M derived: sum of 2 quarters · filed 2022-11-03 | $190.20M 10-Q · filed 2022-11-03 | $230.48M derived: sum of 4 quarters · filed 2023-02-23 |
| 2021-06-30 | $63.72M 10-Q · filed 2022-08-04 | $119.23M 10-Q · filed 2022-08-04 | $159.51M derived: sum of 3 quarters · filed 2023-02-23 | $195.76M derived: sum of 4 quarters · filed 2023-02-23 |
| 2021-03-31 | $55.51M 10-Q · filed 2022-05-05 | $95.79M derived: sum of 2 quarters · filed 2023-02-23 | $132.03M derived: sum of 3 quarters · filed 2023-02-23 | $168.35M derived: sum of 4 quarters · filed 2023-02-23 |
| 2020-12-31 | $40.28M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-23 | $76.53M derived: sum of 2 quarters · filed 2023-02-23 | $112.85M derived: sum of 3 quarters · filed 2023-02-23 | $149.86M 10-K · filed 2023-02-23 |
| 2020-09-30 | $36.24M 10-Q · filed 2021-11-04 | $72.56M derived: sum of 2 quarters · filed 2021-11-04 | $109.58M 10-Q · filed 2021-11-04 | $135.46M derived: sum of 4 quarters · filed 2022-02-24 |
| 2020-06-30 | $36.32M 10-Q · filed 2021-08-05 | $73.33M 10-Q · filed 2021-08-05 | $99.21M derived: sum of 3 quarters · filed 2022-02-24 | $123.78M derived: sum of 4 quarters · filed 2022-02-24 |
| 2020-03-31 | $37.02M 10-Q · filed 2021-05-06 | $62.89M derived: sum of 2 quarters · filed 2022-02-24 | $87.46M derived: sum of 3 quarters · filed 2022-02-24 | $106.99M derived: sum of 4 quarters · filed 2022-02-24 |
| 2019-12-31 | $25.88M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | $50.44M derived: sum of 2 quarters · filed 2022-02-24 | $69.98M derived: sum of 3 quarters · filed 2022-02-24 | $86.29M 10-K · filed 2022-02-24 |
| 2019-09-30 | $24.57M 10-Q · filed 2020-11-05 | $44.10M derived: sum of 2 quarters · filed 2020-11-05 | $60.42M 10-Q · filed 2020-11-05 | $77.07M derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-06-30 | $19.53M 10-Q · filed 2020-08-06 | $35.85M 10-Q · filed 2020-08-06 | $52.50M derived: sum of 3 quarters · filed 2021-02-25 | $66.75M derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-03-31 | $16.32M 10-Q · filed 2020-05-07 | $32.97M derived: sum of 2 quarters · filed 2021-02-25 | $47.22M derived: sum of 3 quarters · filed 2021-02-25 | $58.77M derived: sum of 4 quarters · filed 2021-02-25 |
| 2018-12-31 | $16.65M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | $30.91M derived: sum of 2 quarters · filed 2021-02-25 | $42.46M derived: sum of 3 quarters · filed 2021-02-25 | $50.71M 10-K · filed 2021-02-25 |
| 2018-09-30 | $14.25M 10-Q · filed 2019-11-07 | $25.81M derived: sum of 2 quarters · filed 2019-11-07 | $34.06M 10-Q · filed 2019-11-07 | $42.18M derived: sum of 4 quarters · filed 2020-03-02 |
| 2018-06-30 | $11.55M 10-Q · filed 2019-08-07 | $19.81M 10-Q · filed 2019-08-07 | $27.93M derived: sum of 3 quarters · filed 2020-03-02 | $35.17M derived: sum of 4 quarters · filed 2020-03-02 |
| 2018-03-31 | $8.26M 10-Q · filed 2019-05-10 | $16.38M derived: sum of 2 quarters · filed 2020-03-02 | $23.62M derived: sum of 3 quarters · filed 2020-03-02 | |
| 2017-12-31 | $8.12M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-02 | $15.37M derived: sum of 2 quarters · filed 2020-03-02 | $25.56M 10-K · filed 2020-03-02 | |
| 2017-09-30 | $7.25M 10-Q · filed 2018-11-19 | $17.44M 10-Q · filed 2018-11-19 | ||
| 2016-12-31 | $10.86M 10-K · filed 2019-03-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LABCORP HOLDINGS INC. (LH) | United States | $25.060B | 22.60 |
| QUEST DIAGNOSTICS INC (DGX) | United States | $26.096B | 22.09 |
| Caris Life Sciences, Inc. (CAI) | United States | $9.119B | 47.87 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |